Inari Medical, Inc. (NARI)
NASDAQ: NARI · Real-Time Price · USD
55.45
+1.04 (1.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
Inari Medical Revenue
Inari Medical had revenue of $153.39M in the quarter ending September 30, 2024, with 21.39% growth. This brings the company's revenue in the last twelve months to $574.50M, up 22.41% year-over-year. In the year 2023, Inari Medical had annual revenue of $493.63M with 28.73% growth.
Revenue (ttm)
$574.50M
Revenue Growth
+22.41%
P/S Ratio
5.60
Revenue / Employee
$441,922
Employees
1,300
Market Cap
3.25B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BrightSpring Health Services | 10.59B |
Oscar Health | 8.22B |
Envista Holdings | 2.50B |
NovoCure | 577.74M |
Veracyte | 425.33M |
Rhythm Pharmaceuticals | 112.53M |
Janux Therapeutics | 13.05M |
Verona Pharma | 5.62M |
NARI News
- 3 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation - Accesswire
- 19 days ago - Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd. - GlobeNewsWire
- 19 days ago - Inari Medical Announces Joint Venture in Greater China - GlobeNewsWire
- 7 weeks ago - PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism - GlobeNewsWire
- 7 weeks ago - Inari Medical, Inc. (NARI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Inari Medical Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Okami Medical Announces Closing Of $32.5M Financing - PRNewsWire